{"id":"NCT03123471","sponsor":"Amgen","briefTitle":"A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp","officialTitle":"A Phase 3, Multi-Center, Randomized, Placebo-Controlled, Double-Blind, Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-05-16","primaryCompletion":"2018-08-13","completion":"2019-01-09","firstPosted":"2017-04-21","resultsPosted":"2019-09-04","lastUpdate":"2020-05-13"},"enrollment":303,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis"],"interventions":[{"type":"DRUG","name":"Apremilast","otherNames":["CC-10004"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Apremilast 30 mg BID","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a Phase 3, multicenter, randomized, placebo-controlled, double-blind study of the efficacy and safety of apremilast (CC-10004) in subjects with moderate to severe plaque psoriasis of the scalp.\n\nApproximately 300 subjects with moderate to severe plaque psoriasis of the scalp will be randomized 2:1 to receive either apremilast 30 mg twice daily (BID) or placebo for the first 16 weeks.","primaryOutcome":{"measure":"Percentage of Participants With Scalp Physician Global Assessment (ScPGA) Score of Clear (0) or Almost Clear (1) With at Least a 2-Point Reduction From Baseline","timeFrame":"Baseline to Week 16","effectByArm":[{"arm":"Placebo/Apremilast","deltaMin":13.7,"sd":null},{"arm":"Apremilast","deltaMin":43.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":17},"locations":{"siteCount":45,"countries":["United States","Canada"]},"refs":{"pmids":["37316690","30747550"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":102},"commonTop":["Diarrhoea","Nausea","Headache","Vomiting","Fatigue"]}}